Table 1 Demonstrates the baseline demographics of RSV patients.
From: Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
Characteristics | RSV patients (n = 103) |
|---|---|
Age—year median (Q1-Q3) | 57 (40–73) |
Female sex—no. (%) | 54 (52.4) |
BMI median (Q1–Q3) | 25.3 (21–31.1) |
Smoking—no. (%) | 32 (31.1) |
Comorbidities—no. (%) | |
Respiratory illness | 33 (32) |
Cardiac illness | 54 (52.4) |
Type 2 diabetes mellitus | 20 (19.4) |
Dialysis | 13 (12.6) |
Oncological disease | 24 (23.3) |
SOT | 19 (18.4) |
Clinical or radiological findings for pneumonia—no. (%) | 18 (17.5) |
Respiratory complications—no. (%) | 20 (19.4) |
Cardiac complications—no. (%) | 2 (1.9) |
Superinfections——no. (%) | |
Positive blood culture | 2 (1.9) |
Rapid urine antigen testing for S. pneumoniae | 3 (2.9) |
Positive broncho-alveolar lavage fluid culture | 1 (1) |
Antibiotics administered | 29 (28.2) |
Hospital admission | 45 (43.7) |
ICU admission—no. (%) | 7 (6.8) |
Length of stay—median (Q1–Q3) | 13 (4–23) |
Death—no. (%) | 3 (2.9) |
